SHP2 acts both upstream and downstream of multiple receptor tyrosine kinases to promote basal-like and triple-negative breast cancerFatimah Matalkah, Yehenew M. Agazie|Breast Cancer Research|2016Cited by 52
Inhibition of SHP2 in basal-like and triple-negative breast cells induces basal-to-luminal transition, hormone dependency, and sensitivity to anti-hormone treatmentHua Zhao, Yehenew M. Agazie|BMC Cancer|2015Cited by 20